NN 2211

Known as: 2211, NN, NN-2211, NN2211 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2011
024620012011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
One of the symptoms of diabetes is the progressive development of neuropathies. One mechanism to replace neurons in the CNS is… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Glucagon-like peptide 1 (GLP-1) is potentially a very attractive agent for treating type 2 diabetes. We explored the effect of… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Liraglutide is a long-acting glucagon-like peptide 1 analog designed for once daily injection. This study assessed the… (More)
  • table 1
  • figure 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2004
2004
OBJECTIVE Glucagon-like peptide (GLP)-1 is a gut hormone that exerts incretin effects and suppresses food intake in humans, but… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Glucagon-like peptide 1 (GLP-1) stimulates insulin secretion in a glucose-dependent manner, but its short half-life limits its… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Glucagon-like peptide 1 (GLP-1) is a potent glucose-lowering agent of potential interest for the treatment of type 2 diabetes. To… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
NN2211 is a long-acting, metabolically stable glucagon-like peptide-1 (GLP-1) derivative designed for once daily administration… (More)
  • figure 2
  • figure 3
  • figure 1
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE The primary objective of the present study was to investigate the safety, tolerability, and pharmacokinetics of a… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Glucagon-like peptide-1 (GLP-1), a polypeptide hormone secreted by the l-cells in the gastrointestinal tract, has shown promising… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Postprandial release of the incretin glucagon-like peptide-1 (GLP-1) has been suggested to act as an endogenous satiety factor in… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?